Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRT-064040 Nasal Spray Phase II Trial for Acute Migraine
CTR20254825Phase 2Active
- Sponsor
- Sichuan Prit Pharmaceutical
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PRT-064040 in migraine, sponsored by Sichuan Prit Pharmaceutical. Started Jan 2026; status: active.
02
Drugs
PRT-064040
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20254825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254825.